Price
$46.30
Decreased by -1.13%
Dollar volume (20D)
18.13 M
ADR%
3.34
Earnings report date
Oct 31, 2024
Shares float
50.37 M
Shares short
4.11 M [8.16%]
Shares outstanding
56.89 M
Market cap
2.66 B
Beta
0.75
Price/earnings
N/A
20D range
39.94 47.21
50D range
39.94 53.28
200D range
20.96 53.28

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.

Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias.

The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria.

Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder.

Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Aug 1, 24 -1.69
Decreased by -11.92%
-1.60
Decreased by -5.62%
May 2, 24 -1.45
Increased by +1.36%
-1.65
Increased by +12.12%
Feb 15, 24 -1.72
Decreased by -356.72%
-1.65
Decreased by -4.24%
Nov 2, 23 -1.64
Decreased by -10.07%
-1.70
Increased by +3.53%
Aug 3, 23 -1.51
Increased by +10.12%
-1.56
Increased by +3.21%
May 4, 23 -1.47
Increased by +15.52%
-1.70
Increased by +13.53%
Feb 23, 23 0.67
Increased by +138.51%
-1.62
Increased by +141.36%
Nov 3, 22 -1.49
Increased by +4.49%
-1.76
Increased by +15.34%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 24 8.19 M
Increased by +46.00%
-81.55 M
Decreased by -14.18%
Decreased by -995.84%
Increased by +21.79%
Dec 31, 23 7.10 M
Increased by +64.80%
-95.94 M
Decreased by -155.71%
Decreased by -1.35 K%
Decreased by -133.80%
Sep 30, 23 7.40 M
Increased by +110.44%
-91.32 M
Decreased by -26.13%
Decreased by -1.23 K%
Increased by +40.06%
Jun 30, 23 6.71 M
Increased by +20.24%
-83.81 M
Increased by +2.52%
Decreased by -1.25 K%
Increased by +18.93%
Mar 31, 23 5.61 M
Increased by +574.16%
-71.42 M
Increased by +19.21%
Decreased by -1.27 K%
Increased by +88.02%
Dec 31, 22 4.31 M
Increased by +10.41 M%
172.22 M
Increased by +282.00%
Increased by +4.00 K%
Increased by +100.00%
Sep 30, 22 3.52 M
Increased by +N/A%
-72.40 M
Increased by +18.43%
Decreased by -2.06 K%
Decreased by N/A%
Jun 30, 22 5.58 M
Decreased by -85.05%
-85.97 M
Increased by +0.28%
Decreased by -1.54 K%
Decreased by -567.16%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY